Betaxolol hydrochloride was administered by i.p. injection to adult male Sprague Dawley rats during cocaine withdrawal. PKA regulatory subunit expression and CREB phosphorylation in amygdalar nuclear extracts significantly decreased compared with cocaine-administered animals that did not receive betaxolol during withdrawal. [2]
Betaxolol decreases PKA regulatory subunit expression during cocaine withdrawal
Animal study · Adult male Sprague Dawley rats; cocaine withdrawal; n=5/treatment group [2]
Adult male Sprague Dawley rats undergoing cocaine withdrawal received Betaxolol hydrochloride at 5 mg/kg by i.p. injection. PKA regulatory subunit expression significantly decreased compared with cocaine-administered animals that received no betaxolol during withdrawal.
Conditions shared by the study groups
- Route
- i.p. injection
- Treatment course
- The first dose of betaxolol was administered 24 hours after the final treatment of chronic cocaine or saline. Another dose of betaxolol was administered at 44 hours following cessation of chronic cocaine administration.
- Vehicle
- 0.9 % sodium chloride
- Betaxolol hydrochloride 5 mg/kg
- Model: Adult male Sprague Dawley rats; cocaine withdrawal; n=5/treatment group
Methods and source locations
Compound reported in the paper: Betaxolol hydrochloride; Compound label in the paper: Betaxolol
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animal Use and Care (S1); Materials and Methods > Drug Treatment (S8, S12, S13, S14, S16); Results > Betaxolol blocks cocaine withdrawal-induced increases in amygdalar PKA regulatory subunit expression (S92, S97)
PKA regulatory subunit expression by western blot analysis: PKA regulatory subunit expression by western blot analysis; comparator: cocaine administered animals that did not receive betaxolol treatment during withdrawal (CS) — Results > Betaxolol blocks cocaine withdrawal-induced increases in amygdalar PKA regulatory subunit expression (S92, S97)
Betaxolol hydrochloride 5 mg/kg · Materials and Methods > Drug Treatment (S12, S13, S14, S16); Results > Betaxolol blocks cocaine withdrawal-induced increases in amygdalar PKA regulatory subunit expression (S97)
Betaxolol decreases CREB phosphorylation during cocaine withdrawal
Animal study · Adult male Sprague Dawley rats; cocaine withdrawal; n=5/treatment group [2]
Adult male Sprague Dawley rats undergoing cocaine withdrawal received Betaxolol hydrochloride at 5 mg/kg by i.p. injection. CREB phosphorylation in amygdalar nuclear extracts significantly decreased compared with cocaine-administered animals that received no betaxolol during withdrawal.
Conditions shared by the study groups
- Route
- i.p. injection
- Treatment course
- The first dose of betaxolol was administered 24 hours after the final treatment of chronic cocaine or saline. Another dose of betaxolol was administered at 44 hours following cessation of chronic cocaine administration.
- Vehicle
- 0.9 % sodium chloride
- Betaxolol hydrochloride 5 mg/kg
- Model: Adult male Sprague Dawley rats; cocaine withdrawal; n=5/treatment group
Methods and source locations
Compound reported in the paper: Betaxolol hydrochloride; Compound label in the paper: Betaxolol
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animal Use and Care (S1); Materials and Methods > Drug Treatment (S8, S12, S13, S14, S16); Results > Betaxolol blocks cocaine withdrawal-induced increases in CREB phosphorylation in amygdalar nuclear extracts (S112, S116)
CREB phosphorylation in amygdalar nuclear extracts: CREB phosphorylation in amygdalar nuclear extracts; comparator: cocaine administered animals that did not receive betaxolol treatment during withdrawal (CS) — Results > Betaxolol blocks cocaine withdrawal-induced increases in CREB phosphorylation in amygdalar nuclear extracts (S112, S116)
Betaxolol hydrochloride 5 mg/kg · Materials and Methods > Drug Treatment (S12, S13, S14, S16); Results > Betaxolol blocks cocaine withdrawal-induced increases in CREB phosphorylation in amygdalar nuclear extracts (S116)